×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
16482 views

Programme

18:00
Pourquoi les chirurgiens doivent favoriser les traitements néo-adjuvants ?
Pr Fabien Reyal
 
18:20
Prise en charge des patientes métastatiques synchrones
Pr Jean-Yves Pierga

18:40 Prise en charge des récidives régionales isolées
Dr Sarah Differding
 
19:00 Débat/discussion - Réponses aux questions

 
Réunion modérée par Pr Fabien Reyal

Shooting date : 2021-04-14
Last update : 2022-12-19
2 comments
Join the Discussion
  • Delphine M. Oui je suis là!!!

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Kheloudja B. les tumeurs de 2 cm ou plus HER2 surexprimé , reçoivent une chimiothérapie néoadjuavnte et si pas de yp0yPn0 , du TDM 1 en adjuvant . que disent les données sur les tumemeurs HER2+ qui ne reçoivent de néoadj car petites de taille qui au final recevront herception en adjuvant mais ne connaissant pas leur sensibilité au néoadj , est ce que celles qui n'auraient pas répondu ne rateraient pas le bénéfice du TDM1 en adjuvant , pourquoi pas du néoadj pour toutes lees HER2+?

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      0
      Days
      0
      Hours
      0
      Minutes
      0
      Seconds
      Tuesday, December 2nd 2025 from 06pm to 07:30pm (GMT+1)
      Honolulu : Tuesday, December 2nd 2025 from 07am to 08:30am (GMT+1)
      San Francisco : Tuesday, December 2nd 2025 from 09am to 10:30am (GMT+1)
      New York : Tuesday, December 2nd 2025 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Tuesday, December 2nd 2025 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Tuesday, December 2nd 2025 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Tuesday, December 2nd 2025 from 06pm to 07:30pm (GMT+1)
      Istanbul : Tuesday, December 2nd 2025 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Tuesday, December 2nd 2025 from 09pm to 10:30pm (GMT+1)
      Bangkok : Wednesday, December 3rd 2025 from 12am to 01:30am (GMT+1)
      Shanghai : Wednesday, December 3rd 2025 from 01am to 02:30am (GMT+1)
      Tokyo : Wednesday, December 3rd 2025 from 02am to 03:30am (GMT+1)
      Sydney : Wednesday, December 3rd 2025 from 03am to 04:30am (GMT+1)
      Wellington : Wednesday, December 3rd 2025 from 05am to 06:30am (GMT+1)

      Cancers du sein : nouveautés diagnostiques

      Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Tuesday, March 19th 2024 from 07am to 08:30am (GMT+1)
      San Francisco : Tuesday, March 19th 2024 from 09am to 10:30am (GMT+1)
      New York : Tuesday, March 19th 2024 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Tuesday, March 19th 2024 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Tuesday, March 19th 2024 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
      Istanbul : Tuesday, March 19th 2024 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Tuesday, March 19th 2024 from 09pm to 10:30pm (GMT+1)
      Bangkok : Wednesday, March 20th 2024 from 12am to 01:30am (GMT+1)
      Shanghai : Wednesday, March 20th 2024 from 01am to 02:30am (GMT+1)
      Tokyo : Wednesday, March 20th 2024 from 02am to 03:30am (GMT+1)
      Sydney : Wednesday, March 20th 2024 from 03am to 04:30am (GMT+1)
      Wellington : Wednesday, March 20th 2024 from 05am to 06:30am (GMT+1)

      Prise en charge actuelle pour les cancers du sein triples négatifs métastatiques

      Les webinars du réseau FEM-NET

      Share
      Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Thursday, February 1st 2024 from 07am to 08:30am (GMT+1)
      San Francisco : Thursday, February 1st 2024 from 09am to 10:30am (GMT+1)
      New York : Thursday, February 1st 2024 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Thursday, February 1st 2024 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Thursday, February 1st 2024 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
      Istanbul : Thursday, February 1st 2024 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Thursday, February 1st 2024 from 09pm to 10:30pm (GMT+1)
      Bangkok : Friday, February 2nd 2024 from 12am to 01:30am (GMT+1)
      Shanghai : Friday, February 2nd 2024 from 01am to 02:30am (GMT+1)
      Tokyo : Friday, February 2nd 2024 from 02am to 03:30am (GMT+1)
      Sydney : Friday, February 2nd 2024 from 03am to 04:30am (GMT+1)
      Wellington : Friday, February 2nd 2024 from 05am to 06:30am (GMT+1)

      Prise en charge du cancer du sein métastatique HER2-faible

      Cycle d'enseignement - Le cancer du sein

      Share
      Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Wednesday, March 13th 2024 from 07am to 08:30am (GMT+1)
      San Francisco : Wednesday, March 13th 2024 from 09am to 10:30am (GMT+1)
      New York : Wednesday, March 13th 2024 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Wednesday, March 13th 2024 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Wednesday, March 13th 2024 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
      Istanbul : Wednesday, March 13th 2024 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Wednesday, March 13th 2024 from 09pm to 10:30pm (GMT+1)
      Bangkok : Thursday, March 14th 2024 from 12am to 01:30am (GMT+1)
      Shanghai : Thursday, March 14th 2024 from 01am to 02:30am (GMT+1)
      Tokyo : Thursday, March 14th 2024 from 02am to 03:30am (GMT+1)
      Sydney : Thursday, March 14th 2024 from 03am to 04:30am (GMT+1)
      Wellington : Thursday, March 14th 2024 from 05am to 06:30am (GMT+1)

      Prise en charge du cancer HER2+ métastatique

      Cycle d'enseignement - Le cancer du sein

      Share
      Scroll Up